Ann Clin Microbiol.  2018 Dec;21(4):86-91. 10.5145/ACM.2018.21.4.86.

Comparison of PANA RealTyper HPV Kit with AdvanSure HPV GenoBlot Assay for Human Papillomavirus Genotyping

• Kim YH
• Chung HS
• Lee M

• KMID: 2429652
• DOI: http://doi.org/10.5145/ACM.2018.21.4.86

Abstract

BACKGROUND
The PANA RealTyper HPV kit (PANAGENE, Korea; PANA RealTyper) was developed to genotype human papillomavirus (HPV) and was based on multiplex real-time PCR amplification and melting curve analysis. In this study, we compared PANA RealTyper to the AdvanSure HPV GenoBlot assay (LG Life Sciences, Korea; AdvanSure assay) and attempted to evaluate the performance of PANA RealTyper.
METHODS
A total of 60 cervical specimens were collected from women undergoing routine cervical cancer screening. The AdvanSure assay and PANA RealTyper kit identified the same 20 high-risk genotypes. However, the AdvanSure assay identified 15 low-risk genotypes, while the PANA RealTyper kit identified only 2 but detected 18 low-risk genotypes.
RESULTS
Among the total 60 specimens, 54 high-risk genotypes (40 specimens) and 20 low-risk genotypes (18 specimens) were detected. The agreement rates of the assays ranged from 94.4 to 100% for high-risk genotypes. Among 9 genotypes that were positive in the PANA RealTyper kit but negative in the AdvanSure assay, 7 were confirmed as true positive (HPV genotypes 16 (n=1), 39 (n=1), 52 (n=1), 58 (n=2), 68 (n=2)). Among 4 genotypes that were negative in the PANA RealTyper kit but positive in the AdvanSure assay, 3 were confirmed as HPV genotype 59. Among the 19 low-risk genotypes positive in the AdvanSure assay, there were 2 cases of HPV 6 and 1 case of HPV 11. In comparison, only 1 positive case of HPV 6 was determined by the PANA RealTyper kit.
CONCLUSION
The PANA RealTyper kit was comparable with the AdvanSure assay. The PANA RealTyper kit would be useful and suitable for HPV genotyping in the clinical laboratory.

Keyword

Genotype; Human papillomavirus; Multiplex real-time polymerase chain reaction

MeSH Terms

Biological Science Disciplines
Female
Freezing
Genotype
Human papillomavirus 11
Human papillomavirus 6
Humans*
Korea
Mass Screening
Real-Time Polymerase Chain Reaction
Uterine Cervical Neoplasms

Reference

1. Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003; 16:1–17.

2. Koliopoulos G, Nyaga VN, Santesso N, Bryant A, Martin-Hirsch PP, Mustafa RA, et al. Cytology versus HPV testing for cervical cancer screening in the general population. Cochrane Database Syst Rev. 2017; 8:CD008587.

3. You W, Li S, Du R, Zheng J, Shen A. Epidemiological study of high-risk human papillomavirus infection in subjects with abnormal cytological findings in cervical cancer screening. Exp Ther Med. 2018; 15:412–418.

4. Lagheden C, Eklund C, Lamin H, Kleppe SN, Lei J, Elfström KM, et al. Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer. Br J Cancer. 2018; 118:1377–1381.

5. Kaur P, Aggarwal A, Nagpal M, Oberoi L, Sharma S. Prevalence and clinical utility of human papilloma virus genotyping in patients with cervical lesions. J Obstet Gynaecol India. 2014; 64:279–283.

6. Moreau F, Fetouchi R, Micalessi I, Brejeon V, Bacon N, Jannes G, et al. Detection and genotyping of human papillomavirus by real-time PCR assay. J Clin Virol. 2013; 56:244–249.

7. CLSI. User protocol for evaluation of qualitative test performance; approved guideline-second edition. CLSI document EP12-A2. Wayne, PA: Clinical and Laboratory Standards Institute;2008.

8. Poljak M, Kocjan BJ, Oštrbenk A, Seme K. Commercially available molecular tests for human papillomaviruses (HPV): 2015 update. J Clin Virol. 2016; 76:Suppl 1. S3–S13.

9. Poljak M, Kocjan BJ. Commercially available assays for multiplex detection of alpha human papillomaviruses. Expert Rev Anti Infect Ther. 2010; 8:1139–1162.

10. Kahng J, Oh EJ, Lee HN, Lee DW, Kim Y. Clinical validation of AdvanSure GenoBlot assay as primary screening and test of cure for human papillomavirus infection. Ann Lab Med. 2014; 34:127–133.

11. Chung HS, Lee M. Comparison of the AdvanSure HPV GenoBlot assay with the INNO-LiPA HPV genotyping assay for human papillomavirus genotyping. J Clin Virol. 2014; 60:34–38.

12. Liao Y, Zhou Y, Guo Q, Xie X, Luo E, Li J, et al. Simultaneous detection, genotyping, and quantification of human papilloma-viruses by multicolor real-time PCR and melting curve analysis. J Clin Microbiol. 2013; 51:429–435.